PROGRAM
The 11th Asia-Pacific Primary Liver Cancer Expert MeetingVIRTUAL CONFERENCE August 13-15, 2021
GMT+09:00 (Korea, Japan)
11:50-12:00
Opening
Jinsil Seong (President)
12:00-13:00
SESSION 1: RISK FACTORS, SURVEILLANCE AND PREVENTION
Namiki Izumi (Musashino Red Cross Hospital, Tokyo)
12:00-12:15
Risk Factors and prevention (Primary, Secondary, Tertiary)
Junqi Niu (Jilin Univ., Jilin)
12:15-12:30
Biomarkers for HCC and CC
Kwang-Hyub Han (NECA, Seoul)
12:30-12:45
Current Recommendation for Surveillance
Young Suk Lim (Univ. of Ulsan, Seoul)
12:45-13:00
Discussion
Namiki Izumi (Musashino Red Cross Hospital, Tokyo), Kwang-Hyub Han (NECA, Seoul)
13:00-13:10
Break
13:10-14:10
SESSION 2: DIAGNOSIS AND STAGING FOR HCC AND CC
Hirohisa Yano (Kurume Univ., Kurume)
13:10-13:25
Pathological Diagnosis for HCC and CC: New WHO Classification
Irene Ng (The Univ. of Hong Kong , Hong Kong)
13:25-13:40
Imaging for HCC and CC: Diagnosis and Response Evaluation
Choon Hua Thng (National Cancer Centre Singapore, Singapore)
13:40-13:55
Treatment algorithm of Current Guidelines for HCC
Ann-Lii Cheng (National Taiwan Univ., Taipei)
13:55-14:10
Case Discussion
Hirohisa Yano (Kurume Univ., Kurume), Irene Ng (The Univ. of Hong Kong, Hong Kong)
14:10-14:20
Break
14:20-15:35
SESSION 3: LIVER-DIRECTED THERAPY
Pierce Chow (National Cancer Centre Singapore, Singapore)
14:20-14:35
Surgical Resection: Update for HCC and CC
Kyung-Suk Suh (Seoul National Univ., Seoul)
14:35-14:50
Liver Transplantation: Selection Criteria & Outcomes
Albert Chan (The Univ. of Hong Kong, Hong Kong)
14:50-15:05
Transarterial Chemoembolization (TACE)
Jin Wook Chung (Seoul National Univ., Seoul)
15:05-15:20
Radiation Therapy
Jason Chia-Hsien Cheng (National Taiwan Univ., Taipei)
15:20-15:35
Case Discussion
Pierce Chow (National Cancer Centre Singapore, Singapore), Jason Chia-Hsien Cheng (National Taiwan Univ., Taipei)
15:35-15:50
Break
15:50-16:50
SESSION 4: SYSTEMIC TREATMENT FOR HCC AND CC
Chiun Hsu (National Taiwan Univ., Taipei)
15:50-16:05
Systemic Therapy for HCC
Han Chong Toh (National Cancer Centre Singapore, Singapore)
16:05-16:20
Systemic Therapy for CC
Stephen Chan (The Chinese Univ. of Hong Kong, Hong Kong)
16:20-16:35
Clinical Trial Design and Analysis: Lessons from Trials of Targeted Therapy and Immunotherapy for HCC
Masafumi Ikeda (National Cancer Center Hospital East, Tokyo)
16:35-16:50
Discussion
Chiun Hsu (National Taiwan Univ., Taipei), Han Chong Toh (National Cancer Centre Singapore, Singapore)
16:50-17:00
Closing Remarks
Irene Ng and Chiun Hsu (Education Chairs)
17:00-17:30
APPLE Academy Satellite Symposium